Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Delphine Launay"'
Autor:
Stéphanie Braillard, Delphine Launay, Nageswararao Pulakundam, Vikram Ramanathan, Bhavesh D. Patel, Rakshit Ameta, Jignesh P Patel, Ritika Uppal
Publikováno v:
Bioanalysis. 11:1419-1435
Aim: To develop a bioanalytical method to support pharmacokinetic evaluation of DNDI-VL-2098 in mouse, rat, dog and hamster following oral administration. Results & methodology: A robust LC–MS/MS bioanalytical method was developed to quantify DNDI-
Autor:
Andrew M. Thompson, Vanessa Yardley, Christopher B. Cooper, Stéphanie Braillard, Patrick D. O'Connor, William A. Denny, Louis Maes, Eric Chatelain, Zhenkun Ma, Delphine Launay, Scott G. Franzblau, Baojie Wan
Publikováno v:
ACS medicinal chemistry letters
ACS Med Chem Lett
ACS Med Chem Lett
[Image: see text] Antitubercular 7-substituted 2-nitroimidazo[2,1-b][1,3]oxazines were previously shown to exhibit potent antileishmanial and antitrypanosomal activities, culminating in a new clinical investigational drug for visceral leishmaniasis (
Autor:
William A. Denny, Zhenkun Ma, Eric Chatelain, Scott G. Franzblau, Andrew J. Marshall, Stéphanie Braillard, Andrew M. Thompson, Delphine Launay, Christopher B. Cooper, Patrick D. O'Connor, Louis Maes, Vanessa Yardley, Baojie Wan, Suman Gupta
Publikováno v:
European journal of medicinal chemistry
Previous investigation of the potent antileishmanial properties of antitubercular 7-substituted 2-nitroimidazo[2,1-b][1,3]oxazines with biaryl side chains led to our development of a new clinical candidate for visceral leishmaniasis (DNDI-0690). With
Autor:
Sujata S. Shinde, Louis Maes, Yuehong Wang, Andrew M. Thompson, Delphine Launay, Eric Chatelain, Adrian Blaser, Baojie Wan, Brian D. Palmer, Scott G. Franzblau, Robert F. Anderson, William A. Denny, Zhenkun Ma
Publikováno v:
Bioorganic and medicinal chemistry letters
As part of a quest for backups to the antitubercular drug pretomanid (PA-824), we investigated the unexplored 6-nitro-2,3-dihydroimidazo[2,1-b][1,3]-thiazoles and related-oxazoles. The nitroimidazothiazoles were prepared in high yield from 2-bromo-4-
Autor:
Debnath Bhuniya, Rao Mukkavilli, Rahul Shivahare, Anil M. Deshpande, Ravindra T. Dere, Hari N. Pati, Vadiraj S. Gopinath, Ashok Pradhan, Manjunath Moger, Denis Martin, Suman Gupta, Preeti Vishwakarma, Delphine Launay, Aditya Verma, Sunil K. Puri
Publikováno v:
European Journal of Medicinal Chemistry. 102:582-593
As part of Drugs for Neglected Diseases initiative's lead optimization program for the development of new chemical entities to treat visceral leishmaniasis (VL), a series of aminothiazoles were synthesized and screened for in vitro efficacy, solubili
Autor:
Andrew M, Thompson, Andrew J, Marshall, Louis, Maes, Nigel, Yarlett, Cyrus J, Bacchi, Eric, Gaukel, Stephen A, Wring, Delphine, Launay, Stephanie, Braillard, Eric, Chatelain, Charles E, Mowbray, William A, Denny
Publikováno v:
Bioorganic & Medicinal Chemistry Letters
Graphical abstract
A 900 compound nitroimidazole-based library derived from our pretomanid backup program with TB Alliance was screened for utility against human African trypanosomiasis (HAT) by the Drugs for Neglected Diseases initiative. Poten
A 900 compound nitroimidazole-based library derived from our pretomanid backup program with TB Alliance was screened for utility against human African trypanosomiasis (HAT) by the Drugs for Neglected Diseases initiative. Poten
Autor:
Rama Mohan Hindupur, Delphine Launay, Srinivas A. Kandadai, Hari N. Pati, Vijay Satam, Pawan J. Tambade, Denis Martin, Srinivasa Rao Pedada
Publikováno v:
Organic Process Research & Development. 17:1149-1155
An efficient two-step method for the synthesis of 2-bromo-4-nitroimidazole, 6, a key building block for nitroimidazole drugs, has been developed. The synthesis involves dibromination of 4-nitroimidazole 10 followed by selective debromination using in
Autor:
Andrew M. Thompson, Apoorva Singh, Hari N. Pati, Vijay Satam, Pasumpon Kamaraj, Rama Mohan Hindupur, Delphine Launay, Nakita Antao, Denis Martin, Srinivasa Rao Pedada
Publikováno v:
Organic Process Research & Development
A process suitable for kilogram-scale synthesis of (2R)-2-methyl-6-nitro-2-{[4-(trifluoromethoxy)phenoxy]methyl}-2,3-dihydroimidazo[2,1-b][1,3]oxazole (DNDI-VL-2098, 2), a preclinical drug candidate for the treatment of visceral leishmaniasis, is des
Autor:
Yuehong Wang, Delphine Launay, William A. Denny, Andrew M. Thompson, Zhenkun Ma, Scott G. Franzblau, Adrian Blaser, Louis Maes, Denis Martin, Baojie Wan, Suman Gupta, Patrick D. O'Connor, Vanessa Yardley
Publikováno v:
Journal of medicinal chemistry
6-Nitro-2,3-dihydroimidazo[2,1-b][1,3]oxazole derivatives were initially studied for tuberculosis within a backup program for the clinical trial agent pretomanid (PA-824). Phenotypic screening of representative examples against kinetoplastid diseases
Publikováno v:
Journal of Combinatorial Chemistry. 7:554-560
A polymer-supported analytical construct was used to quantify the reactivity of a range of monomers in the Ugi four-component condensation using positive electrospray ionization mass spectrometry (MS) as a quantitative analytical tool. The construct